Cerus (CERS) | Stock Overview & Key Data
Cerus Performance Comparison
Stock Range
Today's Range
Low: $1.15
High: $1.21
on August 21, 2025
52 Week Range
Low: $1.12
High: $2.39
on April 7, 2025
on August 27, 2024
All-Time High: $81.88 on December 25, 2000
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$237.7M
EPS
-0.10
P/E Ratio (TTM)
-10.82
Forward P/E
-17.71
P/B Ratio
4.29
PEG Ratio
-17.71
Div. Yield
N/A
ROE
-35.56%
Beta
1.548
Debt to Equity
176.07
Financial Highlights
Profitability
Gross Margin
55.25%
Operating Margin
-6.53%
Profit Margin
-9.81%
Returns and Earnings
Return on Assets (TTM)
-3.67%
Return on Equity (TTM)
-35.56%
EBITDA
$-10.3M
Net Income (TTM)
$-18.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1.04
Quarterly Revenue Growth (YoY)
16.30%
Quarterly Earnings Growth (YoY)
16.34%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Cerus CERS | 237.71M Micro-cap | -5.51% | -13.04% | -4.00% | -27.27% | -23.57% | -48.50% | -72.09% | -80.83% |
| Abbott Laboratories ABT | 229.31B Mega-cap | 2.10% | 6.09% | -0.79% | -2.16% | 16.36% | 17.14% | 29.54% | 19.14% |
| Boston Scientific BSX | 153.73B Large-cap | 1.02% | 1.38% | 0.54% | 0.69% | 17.71% | 32.89% | 159.65% | 156.42% |
| TriSalus Life TLSI | 249.84M Micro-cap | 27.84% | 8.53% | -8.82% | -14.04% | -0.40% | -11.59% | -49.90% | -51.94% |
| Outset Medical OM | 237.18M Micro-cap | 6.05% | -21.93% | -26.51% | 4.19% | -22.11% | 28.48% | -95.12% | -98.48% |
| Quanterix QTRX | 233.72M Micro-cap | 6.61% | -6.56% | 0.62% | -35.89% | -55.02% | -64.15% | -48.95% | -86.28% |
Ownership & Short Interest
Insider Ownership
3.33%
Institutional Ownership
73.65%
Shares Short
7M
Short Ratio
7.51
Short % of Shares Outstanding
4.78%
Average 10-Day Volume
1M
Average 90-Day Volume
1M
Cerus Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Cerus would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CERS's 52-week high and low?
- In the last 52 weeks, Cerus reached a high of $2.39 (on August 27, 2024) and a low of $1.12 (on April 7, 2025).
- What is the market cap and P/E ratio for CERS?
- Curious about Cerus's size and valuation? Its market capitalization stands at 237.71M. When it comes to valuation, the P/E ratio (trailing twelve months) is -10.82, and the forward P/E (looking ahead) is -17.71.
- Does CERS pay dividends? If so, what's the yield?
- As for dividends, Cerus isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Cerus's main competitors or similar companies to consider before investing?
When looking at Cerus, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT229.31B Healthcare Medical Devices 17.14% 29.54% Boston Scientific
BSX153.73B Healthcare Medical Devices 32.89% 159.65% TriSalus Life
TLSI249.84M Healthcare Medical Devices -11.59% -49.90% Outset Medical
OM237.18M Healthcare Medical Devices 28.48% -95.12% Quanterix
QTRX233.72M Healthcare Medical Devices -64.15% -48.95% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Cerus Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Cerus's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -35.56%, the Debt to Equity ratio from the most recent quarter is 176.07, and its Gross Profit Margin stands at 55.25%.
- What is the recent revenue and earnings growth for CERS?
- Looking at Cerus's growth, its revenue over the trailing twelve months (TTM) was $193M. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.30%, and quarterly earnings saw a YoY growth of 16.34%.
- How much of CERS stock is held by insiders and institutions?
- Wondering who owns Cerus stock? Company insiders (like executives and directors) hold about 3.33% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 73.65%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.